As of 2026-03-30, 中药配方颗粒's data on the DeepSeek platform in the 医药制造 category shows: The overall mention rate is 1.45%, above the industry average by 1.4 percentage points, showing notable performance. The first mention rate is only 0.00%, it is recommended to enhance first-position exposure in AI model responses. Negative mention rate (0.00%) has exceeded positive (0.00%), it is recommended to immediately initiate reputation repair. Among 6 competitors in the same category, 中药配方颗粒's overall mention rate surpasses 6 brands. AIGeo recommends combining the above data to formulate targeted brand monitoring strategies to further enhance brand visibility and reputation in the AI search ecosystem.
中药配方颗粒's Mention Rate is 1.45%, lower than 0.6% of competitors
中药配方颗粒's First Mention is 0.00%, lower than 0.9% of competitors
中药配方颗粒's Preferred Rate is 0.00%, lower than 100.0% of competitors
中药配方颗粒's Positive Rate is 0.00%, lower than 8.9% of competitors
中药配方颗粒's Negative Rate is 0.00%, higher than 96.3% of competitors
| Competitor | Mention Rate | First Mention | Preferred Rate | Positive Rate | Negative Rate | Actions |
|---|---|---|---|---|---|---|
| 中中药配方颗粒 (Current Brand) | 1.45% | 0% | 0% | 0% | 0% | View Details |
| 软软胶囊 | 0% | 0% | 0% | 0% | 0% | View Details |
| 口口服液 | 0% | 0% | 0% | 0% | 0% | View Details |
| 左左氧氟沙星氯化钠注射液 | 0% | 0% | 0% | 0% | 0% | View Details |
| 颗颗粒剂 | 0% | 0% | 0% | 0% | 0% | View Details |
| 华华堂宁®（多格列艾汀片） | 0% | 0% | 0% | 0% | 0% | View Details |
| 细细胞与基因治疗 | 0% | 0% | 0% | 0% | 0% | View Details |
